Clinical Decision Support With Continuous Glucose Monitoring Data for Managing Type 2 Diabetes
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- HealthPartners Institute
- Study ID
- NCT07394075
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Continuous Glucose Monitoring Clinical Decision Support — OTHERRetrospective CGM data is combined with a readily available EHR-based smart order set tool to assist with guidance and decision support for participants with type 2 diabetes on insulin.
Study Details
The goal of this project is to see if an electronic health record (EHR)-based smart order set with continuous glucose monitoring data to provide decision support can improve blood sugar management in people with type 2 diabetes (T2D) using insulin.
Key Dates
- Start date
- Mar 4, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 150 participants (estimated)
Primary Outcome Measure
Change in % glucose management indicator (GMI%) [ Time Frame: Baseline and 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| HealthPartners Medical Group | Minneapolis | Minnesota | 55440 | - |
Find similar trials in Minneapolis, MN
By condition
By specialty
By research site
Related Studies
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesRecruiting · Endogenex, Inc. · Birmingham, Alabama
- Personalized Nutrition for Type 2 DiabetesRecruiting · University of Minnesota · Minneapolis, Minnesota
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesPHASE2 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes ManagementRecruiting · Katherine Vickery · Minneapolis, Minnesota